ALT
Secured a major medical distributor. Initial rollout in Brazil followed by the rest of South America.
Expecting 30% YOY growth.
Also ...
"High level negotiations are continuning in US and European markets and anticipate a positive outcome in 2013"
Should be cashflow positive on this and well overdue for a rerate.
2.3c clear for a retest of 3.4c
